Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul R Ingram

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 25, 2019
Non-adherence to antimicrobial stewardship prospective audit and feedback advice: Risk factors and clinical consequencesChristopher D Horton, Matthew D M Rawlins, Laurens Manning, et al.
Journal of Medical Microbiology|March 6, 2016
Temporal flux in β-lactam resistance among Klebsiella pneumoniae in Western AustraliaJarrad M Hall, Paul R Ingram, Lyn C O'Reilly, et al.
Internal Medicine Journal|October 19, 2021
Subcutaneous ertapenem delivered by an Australian outpatient parenteral antimicrobial therapy service: a retrospective comparative efficacy studyJonathan Hiew, Timothy Whitmore, Mahalia McEvoy, et al.
Communicable Diseases Intelligence Quarterly Report|November 25, 2010
Zoonotic tuberculosis: on the declinePaul R Ingram, Peter Bremner, Tim J Inglis, et al.
Internal Medicine Journal|November 12, 2025
Tolerability of subcutaneous teicoplanin administration in an Australian tertiary hospital clinical settingSarah S J Clark, Matthew D M Rawlins, Paul R Ingram, et al.
Free Radical Research|September 30, 2004
A comparison of the effects of ocular preservatives on mammalian and microbial ATP and glutathione levelsPaul R Ingram, Andrew R Pitt, Clive G Wilson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 11, 2012
Potential utility for nomogram-based vancomycin dosingEmma K Elshaug, Laurens Manning, Matthew D M Rawlins, et al.
International Journal of Antimicrobial Agents|September 12, 2009
Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapyPaul R Ingram, David C Lye, Dale A Fisher, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2007
Molecular basis for resistance of acanthamoeba tubulins to all major classes of antitubulin compoundsFiona L Henriquez, Paul R Ingram, Stephen P Muench, et al.
Jac-Antimicrobial Resistance|August 11, 2021
A clinical and <i>in vitro</i> assessment of outpatient parenteral benzylpenicillin and ceftriaxone combination therapy for enterococcal endovascular infectionsPaul R Ingram, Jacinta Ng, Claire Mathieson, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 25, 2019
Non-adherence to antimicrobial stewardship prospective audit and feedback advice: Risk factors and clinical consequencesChristopher D Horton, Matthew D M Rawlins, Laurens Manning, et al.
Journal of Medical Microbiology|March 6, 2016
Temporal flux in β-lactam resistance among Klebsiella pneumoniae in Western AustraliaJarrad M Hall, Paul R Ingram, Lyn C O'Reilly, et al.
Internal Medicine Journal|October 19, 2021
Subcutaneous ertapenem delivered by an Australian outpatient parenteral antimicrobial therapy service: a retrospective comparative efficacy studyJonathan Hiew, Timothy Whitmore, Mahalia McEvoy, et al.
Communicable Diseases Intelligence Quarterly Report|November 25, 2010
Zoonotic tuberculosis: on the declinePaul R Ingram, Peter Bremner, Tim J Inglis, et al.
Internal Medicine Journal|November 12, 2025
Tolerability of subcutaneous teicoplanin administration in an Australian tertiary hospital clinical settingSarah S J Clark, Matthew D M Rawlins, Paul R Ingram, et al.
Free Radical Research|September 30, 2004
A comparison of the effects of ocular preservatives on mammalian and microbial ATP and glutathione levelsPaul R Ingram, Andrew R Pitt, Clive G Wilson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 11, 2012
Potential utility for nomogram-based vancomycin dosingEmma K Elshaug, Laurens Manning, Matthew D M Rawlins, et al.
International Journal of Antimicrobial Agents|September 12, 2009
Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapyPaul R Ingram, David C Lye, Dale A Fisher, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2007
Molecular basis for resistance of acanthamoeba tubulins to all major classes of antitubulin compoundsFiona L Henriquez, Paul R Ingram, Stephen P Muench, et al.
Jac-Antimicrobial Resistance|August 11, 2021
A clinical and <i>in vitro</i> assessment of outpatient parenteral benzylpenicillin and ceftriaxone combination therapy for enterococcal endovascular infectionsPaul R Ingram, Jacinta Ng, Claire Mathieson, et al.
Pageof 6